Skip to main content

Rock Springs Capital Management LP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1595725 Baltimore, MD

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$19,820,283
+$2,020,618 QoQ
Shares Held
150,450
+19.9% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Rock Springs Capital Management LP holds $43,551,047 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (45.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
150,450 $19,820,283

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $19,820,283 150,450
2025-12-31 $17,799,665 125,500
2025-09-30 $12,599,105 89,750
2025-06-30 $11,161,272 88,800
2025-03-31 $30,857,400 279,000
2024-12-31 $98,348,250 720,500
2024-09-30 $108,191,580 939,000
2024-06-30 $129,409,800 940,000
2024-03-31 $145,491,808 1,054,900
2023-12-31 $157,584,960 1,196,000
2023-09-30 $139,050,000 1,236,000
2023-06-30 $120,656,850 1,279,500
2023-03-31 $122,486,322 1,210,100
2022-12-31 $134,071,400 1,122,500
2022-09-30 $119,220,725 1,122,500
2022-06-30 $109,421,300 1,122,500
2022-03-31 $103,593,750 1,105,000
2021-12-31 $94,112,850 1,105,000
2021-09-30 $100,849,365 1,051,500
2021-06-30 $98,779,800 1,015,000
2021-03-31 $98,708,750 1,015,000
2020-12-31 $150,963,750 1,575,000
2020-09-30 $140,922,480 1,465,500
2020-06-30 $166,713,000 1,366,500
2020-03-31 $116,799,225 1,349,500